Julia Yi1, Danielle Zielinski2, Bichun Ouyang3, James Conners3, Rima Dafer3, Michael Chen2. 1. University of Illinois at Chicago, Chicago, Illinois, USA. 2. Department of Neurological Surgery, Rush University Medical Center, Chicago, Illinois, USA. 3. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Abstract
BACKGROUND: Most patients with large vessel occlusion (LVO) stroke need to be transferred to receive thrombectomy. To save time, the decision to transfer often relies on clinical scales as a surrogate for LVO rather than imaging. However, clinical scales have been associated with high levels of diagnostic error. The aim of this study is to define the susceptibility to overdiagnosis of our current transfer decision process by measuring the rate of non-treatment transfers, the most common reasons for no treatment and potential predictors. METHODS: Clinical and transfer data on consecutive patients transferred to a single endovascular capable centre for possible thrombectomy via stroke code activation were retrospectively reviewed. Whether patients underwent the procedure, why they did not undergo the procedure, and other clinical and logistical predictors were recorded. χ2 tests and multivariate logistic regression analysis were performed. RESULTS: From 2015 to 2016, 105/192 transferred patients (54%) did not undergo thrombectomy and the most common reason was absence of a LVO found on CTA after transfer (71/104 (68%)). 14/16 (88%) with a National Institutes of Health Stroke Scale (NIHSS) score <10 did not undergo thrombectomy while 41/78 (52%) with a NIHSS>20 underwent thrombectomy (p<0.001). Helicopter use was associated with no treatment (p=0.004) while arrival within 5 hours was associated with treatment (p<0.001). CONCLUSIONS: Clinical scales appear to overdiagnose LVO and may be responsible for the majority of our stroke code transfers not undergoing thrombectomy. Primary stroke centres therefore have reason to develop the capability to rapidly acquire and interpret a CTA in patients with suspected LVO prior to transfer. Such efforts may reduce the costs associated with unnecessary thrombectomy transfers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: Most patients with large vessel occlusion (LVO) stroke need to be transferred to receive thrombectomy. To save time, the decision to transfer often relies on clinical scales as a surrogate for LVO rather than imaging. However, clinical scales have been associated with high levels of diagnostic error. The aim of this study is to define the susceptibility to overdiagnosis of our current transfer decision process by measuring the rate of non-treatment transfers, the most common reasons for no treatment and potential predictors. METHODS: Clinical and transfer data on consecutive patients transferred to a single endovascular capable centre for possible thrombectomy via stroke code activation were retrospectively reviewed. Whether patients underwent the procedure, why they did not undergo the procedure, and other clinical and logistical predictors were recorded. χ2 tests and multivariate logistic regression analysis were performed. RESULTS: From 2015 to 2016, 105/192 transferred patients (54%) did not undergo thrombectomy and the most common reason was absence of a LVO found on CTA after transfer (71/104 (68%)). 14/16 (88%) with a National Institutes of Health Stroke Scale (NIHSS) score <10 did not undergo thrombectomy while 41/78 (52%) with a NIHSS>20 underwent thrombectomy (p<0.001). Helicopter use was associated with no treatment (p=0.004) while arrival within 5 hours was associated with treatment (p<0.001). CONCLUSIONS: Clinical scales appear to overdiagnose LVO and may be responsible for the majority of our stroke code transfers not undergoing thrombectomy. Primary stroke centres therefore have reason to develop the capability to rapidly acquire and interpret a CTA in patients with suspected LVO prior to transfer. Such efforts may reduce the costs associated with unnecessary thrombectomy transfers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Mohammad Anadani; Eyad Almallouhi; Amy E Wahlquist; Ellen Debenham; Christine A Holmstedt Journal: Telemed J E Health Date: 2019-02-12 Impact factor: 3.536
Authors: Susmita Chennareddy; Roshini Kalagara; Colton Smith; Stavros Matsoukas; Abhiraj Bhimani; John Liang; Steven Shapiro; Reade De Leacy; Maxim Mokin; Johanna T Fifi; J Mocco; Christopher P Kellner Journal: BMC Emerg Med Date: 2022-06-16
Authors: A T Yu; R W Regenhardt; C Whitney; L H Schwamm; A B Patel; C J Stapleton; A Viswanathan; J A Hirsch; M Lev; T M Leslie-Mazwi Journal: AJNR Am J Neuroradiol Date: 2021-02-04 Impact factor: 3.825
Authors: Michael T Froehler; Jeffrey L Saver; Osama O Zaidat; Reza Jahan; Mohammad Ali Aziz-Sultan; Richard P Klucznik; Diogo C Haussen; Frank R Hellinger; Dileep R Yavagal; Tom L Yao; David S Liebeskind; Ashutosh P Jadhav; Rishi Gupta; Ameer E Hassan; Coleman O Martin; Hormozd Bozorgchami; Ritesh Kaushal; Raul G Nogueira; Ravi H Gandhi; Eric C Peterson; Shervin R Dashti; Curtis A Given; Brijesh P Mehta; Vivek Deshmukh; Sidney Starkman; Italo Linfante; Scott H McPherson; Peter Kvamme; Thomas J Grobelny; Muhammad S Hussain; Ike Thacker; Nirav Vora; Peng Roc Chen; Stephen J Monteith; Robert D Ecker; Clemens M Schirmer; Eric Sauvageau; Alex Abou-Chebl; Colin P Derdeyn; Lucian Maidan; Aamir Badruddin; Adnan H Siddiqui; Travis M Dumont; Abdulnasser Alhajeri; M Asif Taqi; Khaled Asi; Jeffrey Carpenter; Alan Boulos; Gaurav Jindal; Ajit S Puri; Rohan Chitale; Eric M Deshaies; David H Robinson; David F Kallmes; Blaise W Baxter; Mouhammad A Jumaa; Peter Sunenshine; Aniel Majjhoo; Joey D English; Shuichi Suzuki; Richard D Fessler; Josser E Delgado Almandoz; Jerry C Martin; Nils H Mueller-Kronast Journal: Circulation Date: 2017-09-24 Impact factor: 29.690
Authors: Christopher P Kellner; Eric Sauvageau; Kenneth V Snyder; Kyle M Fargen; Adam S Arthur; Raymond D Turner; Andrei V Alexandrov Journal: J Neurointerv Surg Date: 2018-03-06 Impact factor: 5.836
Authors: Kori S Zachrison; Thabele M Leslie-Mazwi; Gregoire Boulouis; Joshua N Goldstein; Robert W Regenhardt; Anand Viswanathan; Arne Lauer; Khawdja Ahmer Siddiqui; Andreas Charidimou; Natalia Rost; Lee H Schwamm Journal: Neurol Clin Pract Date: 2019-10